Kewaunee Scientific (KEQU) Revenue (2010 - 2026)

Kewaunee Scientific's Revenue history runs 17 years deep, the most recent figure standing at $71.4 million for Q2 2026.

• On a quarterly basis, Revenue fell 7.45% year-over-year to $71.4 million in Q2 2026; TTM through Apr 2026 was $282.0 million, a 17.27% increase from a year earlier, with the FY2026 full-year figure at $282.0 million, up 17.27% from the prior year.
• Revenue improved to $71.4 million in Q2 2026 per KEQU's latest filing, from $69.4 million in the prior quarter.
• Across five years, Revenue topped out at $77.1 million in Q2 2025 and bottomed at $40.6 million in Q1 2022.
• The 5-year median for Revenue is $54.3 million (2022), against an average of $57.6 million.
• Across the five-year window, Revenue jumped 49.68% in 2023 and retreated 23.09% in 2024, its largest moves.
• Year by year, Revenue stood at $54.6 million in 2022, then slipped by 7.57% to $50.4 million in 2023, then declined by 5.3% to $47.8 million in 2024, then surged by 46.75% to $70.1 million in 2025, then increased by 1.86% to $71.4 million in 2026.
• Per Business Quant, the three latest KEQU Revenue figures stand at $71.4 million (Q2 2026), $69.4 million (Q1 2026), and $70.1 million (Q4 2025).